RAC

1.09%

$1.36

RACE ONCOLOGY LTD

Market Cap $236.2M Add to my watchlist

Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag

Subject

RAC

CPACS: Research, Results, Market Comparisons, and Valuations

4 5 6

00:46

319

103K

00:46

Last post Boffin99

319

103K

RAC

Ann: Race Submits Human Ethics for RC220 Phase 1 Trial

4 5 6

28/12/24

340

97K

28/12/24

Last post Kron00

340

97K

RAC

Ann: Race Strengthens Board

27/12/24

15K

27/12/24

Last post Rhino1963

15K

RAC

Industry news

43 44 45

27/12/24

2.6K

899K

27/12/24

Last post EWexplorer

2.6K

899K

RAC

RAC Charts

29 30 31

25/12/24

1.8K

1.0M

25/12/24

Last post Thinkman

1.8K

1.0M

RAC

General Comments / Chat

202 203 204

24/12/24

12K

4.3M

24/12/24

Last post Hunterr

12K

4.3M

RAC Biotech

RAC - Charts & Price Action

392 393 394

23/12/24

23K

8.3M

23/12/24

Last post

slick

23K

8.3M

RAC

Pillar 1 - FTO (new thread)

50 51 52

23/12/24

3.0K

1.1M

23/12/24

Last post raisinsareheresy

3.0K

1.1M

RAC

Cardioprotection thread

15 16 17

22/12/24

988

310K

22/12/24

Last post johndprent

988

310K

RAC

RAC media coverage

38 39 40

18/12/24

2.3K

814K

18/12/24

Last post Boffin99

2.3K

814K

RAC

Is RAC undervalued? the rNPV says...

18/12/24

13K

18/12/24

Last post DrSanchez

13K

RAC

Ann: Race Receives $5.25m RD Tax Refund for Financial Year 2024

17/12/24

4.8K

17/12/24

Last post

Davisite

4.8K

RAC

Ann: Race Oncology 2024 Chairs Address and AGM Presentation

4 5 6

17/12/24

342

85K

17/12/24

Last post johndprent

342

85K

RAC

Dr Daniel Tillett

12/12/24

2.9K

12/12/24

Last post phmurphy01

2.9K

RAC

RAC "eye opener" Series

11/12/24

102

27K

11/12/24

Last post IndexInvestor

102

27K

RAC

RAC - Crystal ball gazing

07/12/24

15K

07/12/24

Last post Rhino1963

15K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Race Strengthens Board
18 Dec 08:53	Share

Race Receives $5.25m RD Tax Refund for Financial Year 2024
17 Dec 10:26	Share

Race Submits Human Ethics for RC220 Phase 1 Trial
05 Dec 08:44	Share

Race 2024 Annual General Meeting Video Release
28 Nov 14:44	Share

Appendix 3Y - Dr Serge Scrofani
26 Nov 17:40	Share

Notification regarding unquoted securities - RAC
26 Nov 17:28	Share

Results of Annual General Meeting
25 Nov 13:41	Share

Race Oncology 2024 Chairs Address and AGM Presentation
25 Nov 09:28	Share

Application for quotation of securities - RAC
22 Nov 14:53	Share

Race Discovers Multiple Novel FTO Inhibitor Candidates
21 Nov 09:25	Share

Notification regarding unquoted securities - RAC
07 Nov 15:41	Share

Annual Report to Shareholders
23 Oct 12:28	Share

Letter to Shareholders, Notice of AGM & Proxy Form
23 Oct 12:27	Share

Quarterly Activity Report and Appendix 4C
21 Oct 10:27	Share

Application for quotation of securities - RAC
17 Oct 13:37	Share

Date of AGM & Closing Date for Director Nominations
07 Oct 08:59	Share

Application for quotation of securities - RAC
03 Oct 13:20	Share

Notification of cessation of securities - RAC
02 Oct 08:24	Share

Application for quotation of securities - RAC
26 Sep 11:07	Share

E&P Conference Presentation
26 Sep 11:07	Share

HealthInvest 2024 Investor Presentation
18 Sep 09:50	Share

Application for quotation of securities - RAC
13 Sep 13:12	Share

Application for quotation of securities - RAC
05 Sep 12:48	Share

Notification of cessation of securities - RAC
05 Sep 09:33	Share

Appendix 3X - Dr Serge Scrofani
02 Sep 09:15	Share

Appendix 3X - Dr Daniel Tillett
02 Sep 09:14	Share

Appendix 3Z - Phillip Lynch
02 Sep 09:13	Share

Appendix 3Z - Mary Harney
02 Sep 09:12	Share

Race Oncology Board Renewal Update
02 Sep 09:04	Share

Application for quotation of securities - RAC
29 Aug 11:07	Share

View More

(20min delay)
Last $1.36		Change -0.015(1.09%)		Mkt cap ! $236.2M

Open	High	Low	Value	Volume
$1.38	$1.39	$1.36	$36.48K	26.62K

Buyers (Bids)

No.	Vol.	Price($)
1	584	$1.36

Sellers (Offers)

Price($)	Vol.	No.
$1.39	550	1

View Market Depth

No.	Vol.	Price($)
1	584	1.360
2	2900	1.350
1	2255	1.330
1	380	1.320
3	3676	1.315

Price($)	Vol.	No.
1.390	550	1
1.400	2713	2
1.410	20000	1
1.415	1499	1
1.420	324	1

Last trade - 16.10pm 27/12/2024 (20 minute delay)

RAC (ASX) Chart

RACE ONCOLOGY LTD

Corporate Spotlight

Latest Threads

Corporate Spotlight

Timeline

Featured News

Latest Videos

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

14 May 2024 09:56 (AEST)

Race Oncology (ASX:RAC) strikes contracts to start observational breast cancer trial

13 Mar 2023 15:00 (AEDT)

Race Oncology (ASX:RAC) enters new collaboration investigating heart protection during chemo

02 Mar 2023 15:49 (AEDT)

Latest Articles

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University in Melbourne

Race delivers promising results in cancer drug mice research into heart complications

Race Oncology (ASX:RAC) has announced a preclinical breakthrough in heart toxicity side effects caused by the carfilzomib, which had precluded the drug being administered to patients diagnosed with elevated cardiac risk factors.In work performed under contract by Labcorp in the United States, Rac...

Race Oncology flags bisantrene "anticancer" properties in animals

Race Oncology (ASX:RAC) presented some major advancements in the potential treatment of Acute Myeloid Leukemia (AML)

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News